On 16th October, CDMO Xanax Health (27.370, 0.92, 3.48%), a world-renowned nutritional and health food company, held a ceremony to inaugurate a new automated packaging production line
at its industrial park in Pritzwalck, Germany. More than 100 guests, including customers and partners of Xanadu, Dr Ronald Thiel, Mayor of Pritzwalck, Mr Lin Peiqing, Chairman and CEO of
Xanadu, Ms Sara Lesina, General Manager of Xanadu Europe and Americas, the management team of Xanadu, and representatives of Xanadu's employees in Europe, Americas and Asia-Pacific,
attended the ceremony and witnessed the milestone moment together. milestone moment.
Highlights of the inauguration ceremony
With an investment of up to 16 million euros, the newly completed packaging line is capable of efficiently handling bulk orders as well as flexibly supporting the packaging needs of private labels.
This signifies that Xanax Health Pritzwalck Industrial Park in Germany has the ability to provide customers in Europe with complete end-to-end solutions from formulation development to final
product packaging, which further promotes Xanax Health's business expansion and supply chain layout on a global scale.
New automated packaging workshop
Pharmaceutical-grade production standards, casting ‘immortal’ quality productivity
SIRIO
SIRIO's pursuit of excellence has always been a priority for the company. The new packaging line also incorporates high standards of quality control throughout the entire production process, ensuring
that pharmaceutical-grade and food-grade softgel capsules can be seamlessly transferred from the production site to the packaging stage.
The new automated packaging line introduces two state-of-the-art production lines for bottling and blistering, which operate in accordance with pharmaceutical-grade Good Manufacturing Practices
(GMP) standards, which will significantly shorten the lead time to as little as three weeks and significantly increase production capacity.
New Bottling Lines
The high-speed bottle line is capable of customising up to 5 million bottles per year, ranging from 75 ml to 400 ml. The blister line, on the other hand, has a capacity of 20 million blister packs
per year and can provide customised services for oval and olive softgel capsules, covering 10 blister types.
New Blister Production Line
Digitalisation for quality and efficiency, green and sustainable practices
SIRIO
To better meet market demands, the new automated packaging line is equipped with advanced visual inspection systems and process control technologies. These systems incorporate
the latest digital technology to monitor key parameters in real time, including product appearance, grammage and metal detection, to ensure that products meet high quality standards.
Xianle Health has been committed to promoting the green transformation and upgrading of the nutritional and health food industry, and actively responding to the United Nations
Sustainable Development Goals to contribute to the sustainable development of the industry. The new packaging line is equipped with energy-saving heat pumps, energy recovery
technology and solar (4.720, 0.05, 1.07%) panels, which can reduce energy consumption and emissions during the production process and improve the recycling rate of resources.
New automated packaging production plant
In addition, the Pritzwalck Industrial Park has passed a number of international standards and certifications such as the EU Organic Product Certification (EC Regulation 2018/848),
Friend of the Sea (FOS), the Marine Stewardship Council's Chain of Custody Standard (MSC), the International Food Standard (IFS Food), and the BRCGS, which demonstrates the
efforts made by the Pritzwalck Industrial Park in the areas of product quality, the production environment, and sustainable development. The Pritzwalsk Industrial Park's efforts
in product quality, production environment and sustainable development are highlighted.
Xanadu Health
Chairman and Chief Executive Officer
Lin Peiqing
The successful completion of the new packaging line marks another solid step in the global supply chain of Xanadu Health. This important milestone not only strengthens
the production capacity of the Pritzwalck Industrial Park, but also deepens our service network in the global market, ensuring that we can continue to provide our customers
with cutting-edge, reliable and efficient supply security.
Xanax Health is committed to being an innovative leader in the field of nutrition and health and the first choice of our customers, and through this modern German
production site we offer consumers in Europe and around the
world high-quality products that promote health and well-being.
Xanax Health
General Manager, Europe and Americas
Sara Lesina
In recent years, Xanax Health has made remarkable achievements in Europe. At the same time, we have continued to invest in advanced manufacturing
technologies to ensure that we can provide even better products and services to our customers. With our new automated packaging line, we will be able
to provide full service in the development and production of pharmaceutical-grade softgel capsules in Europe and, with more than 30 years of experience
in the nutritional and health food industry, we will ensure that our customers' products enjoy pharmaceutical-grade quality assurance at every stage of production.
